Annovis Bio, Inc. (ANVS)

Annovis Bio Statistics

Total Valuation

Annovis Bio has a market cap or net worth of $130.39 million. The enterprise value is $115.11 million.

Market Cap	130.39M
Enterprise Value	115.11M

Important Dates

The last earnings date was Wednesday, November 12, 2025, before market open.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Annovis Bio has 26.50 million shares outstanding. The number of shares has increased by 61.36% in one year.

Current Share Class	26.50M
Shares Outstanding	26.50M
Shares Change (YoY)	+61.36%
Shares Change (QoQ)	+1.02%
Owned by Insiders (%)	15.13%
Owned by Institutions (%)	11.46%
Float	22.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	7.55
P/TBV Ratio	9.91
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.60

Current Ratio	4.60
Quick Ratio	4.09
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -246.14% and return on invested capital (ROIC) is -165.21%.

Return on Equity (ROE)	-246.14%
Return on Assets (ROA)	-105.88%
Return on Invested Capital (ROIC)	-165.21%
Return on Capital Employed (ROCE)	-198.62%
Revenue Per Employee	n/a
Profits Per Employee	-$1.66M
Employee Count	15
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -30.41% in the last 52 weeks. The beta is 1.61, so Annovis Bio's price volatility has been higher than the market average.

Beta (5Y)	1.61
52-Week Price Change	-30.41%
50-Day Moving Average	2.39
200-Day Moving Average	2.22
Relative Strength Index (RSI)	86.77
Average Volume (20 Days)	3,641,008

Short Selling Information

The latest short interest is 1.03 million, so 3.90% of the outstanding shares have been sold short.

Short Interest	1.03M
Short Previous Month	1.40M
Short % of Shares Out	3.90%
Short % of Float	4.59%
Short Ratio (days to cover)	0.84

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-26.72M
Pretax Income	-24.88M
Net Income	-24.88M
EBITDA	n/a
EBIT	-26.72M
Earnings Per Share (EPS)	-$1.44

Balance Sheet

The company has $15.29 million in cash and n/a in debt, giving a net cash position of $15.29 million or $0.58 per share.

Cash & Cash Equivalents	15.29M
Total Debt	n/a
Net Cash	15.29M
Net Cash Per Share	$0.58
Equity (Book Value)	13.16M
Book Value Per Share	0.65
Working Capital	13.46M

Cash Flow

Operating Cash Flow	-24.98M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Annovis Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-61.36%
Shareholder Yield	-61.36%
Earnings Yield	-19.08%
FCF Yield	n/a

Analyst Forecast

The average price target for Annovis Bio is $13.50, which is 174.39% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.50
Price Target Difference	174.39%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-29.63%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1